164 related articles for article (PubMed ID: 34387598)
1. Circ_0085495 knockdown reduces adriamycin resistance in breast cancer through miR-873-5p/integrin β1 axis.
Xie H; Zheng R
Anticancer Drugs; 2022 Jan; 33(1):e166-e177. PubMed ID: 34387598
[TBL] [Abstract][Full Text] [Related]
2. Knockdown of circ_0006528 Suppresses Cell Proliferation, Migration, Invasion, and Adriamycin Chemoresistance via Regulating the miR-1236-3p/CHD4 Axis in Breast Cancer.
Hao J; Du X; Lv F; Shi Q
J Surg Res; 2021 Apr; 260():104-115. PubMed ID: 33333383
[TBL] [Abstract][Full Text] [Related]
3. Circ_0001667 Promotes Adriamycin Resistance and Malignant Progression via Targeting the miR-193a-5p/Rap2A Molecular Axis in Breast Cancer.
Xu S; Luo W; Li M; Li Q; Hong W; Gao Y; Yang J; Song H; Chen L; Yang Y; Yang C
Clin Breast Cancer; 2023 Jan; 23(1):71-83. PubMed ID: 36289041
[TBL] [Abstract][Full Text] [Related]
4. CircATXN7 contributes to the progression and doxorubicin resistance of breast cancer via modulating miR-149-5p/HOXA11 pathway.
Wang H; Shan S; Wang H; Wang X
Anticancer Drugs; 2022 Jan; 33(1):e700-e710. PubMed ID: 34845164
[TBL] [Abstract][Full Text] [Related]
5. Circ_0001667 knockdown blocks cancer progression and attenuates adriamycin resistance by depleting NCOA3 via releasing miR-4458 in breast cancer.
Cui Y; Fan J; Shi W; Zhou Z
Drug Dev Res; 2022 Feb; 83(1):75-87. PubMed ID: 34227151
[TBL] [Abstract][Full Text] [Related]
6. Circ-RNF111 contributes to paclitaxel resistance in breast cancer by elevating E2F3 expression via miR-140-5p.
Zang H; Li Y; Zhang X; Huang G
Thorac Cancer; 2020 Jul; 11(7):1891-1903. PubMed ID: 32445273
[TBL] [Abstract][Full Text] [Related]
7. Depletion of circ_0007841 inhibits multiple myeloma development and BTZ resistance via miR-129-5p/JAG1 axis.
Wang Y; Lin Q; Song C; Ma R; Li X
Cell Cycle; 2020 Dec; 19(23):3289-3302. PubMed ID: 33131409
[TBL] [Abstract][Full Text] [Related]
8. Circ_KIAA1199 inhibits MSI1 degradation by targeting miR-34c-5p to drive the malignant cell behaviors and tumor growth of colorectal cancer.
Zhang Y; Yu H; Guo Z
Anticancer Drugs; 2022 Jan; 33(1):e134-e144. PubMed ID: 34387591
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of circ_CELSR1 facilitates paclitaxel resistance of ovarian cancer by regulating miR-149-5p/SIK2 axis.
Wei S; Qi L; Wang L
Anticancer Drugs; 2021 Jun; 32(5):496-507. PubMed ID: 33735118
[TBL] [Abstract][Full Text] [Related]
10. Circ_PIP5K1A regulates cisplatin resistance and malignant progression in non-small cell lung cancer cells and xenograft murine model via depending on miR-493-5p/ROCK1 axis.
Feng N; Guo Z; Wu X; Tian Y; Li Y; Geng Y; Yu Y
Respir Res; 2021 Sep; 22(1):248. PubMed ID: 34537072
[TBL] [Abstract][Full Text] [Related]
11. Circular RNA circ-FAM158A promotes retinoblastoma progression by regulating miR-138-5p/SLC7A5 axis.
Zheng T; Chen W; Wang X; Cai W; Wu F; Lin C
Exp Eye Res; 2021 Oct; 211():108650. PubMed ID: 34102206
[TBL] [Abstract][Full Text] [Related]
12. Circ_0005875 sponges miR-502-5p to promote renal cell carcinoma progression through upregulating E26 transformation specific-1.
Luo S; Deng F; Yao N; Zheng F
Anticancer Drugs; 2022 Jan; 33(1):e286-e298. PubMed ID: 34407050
[TBL] [Abstract][Full Text] [Related]
13. Circ_0001821 knockdown suppresses growth, metastasis, and TAX resistance of non-small-cell lung cancer cells by regulating the miR-526b-5p/GRK5 axis.
Liu Y; Li C; Liu H; Wang J
Pharmacol Res Perspect; 2021 Aug; 9(4):e00812. PubMed ID: 34219377
[TBL] [Abstract][Full Text] [Related]
14. Circular RNA hsa_circ_0000277 promotes tumor progression and DDP resistance in esophageal squamous cell carcinoma.
Cheng J; Zhang R; Yan M; Li Y
BMC Cancer; 2022 Mar; 22(1):238. PubMed ID: 35241028
[TBL] [Abstract][Full Text] [Related]
15. Knockdown of circ_0011946 targets miR-216a-5p/BCL2L2 axis to regulate proliferation, migration, invasion and apoptosis of oral squamous cell carcinoma cells.
Zhou Y; Zhang S; Min Z; Yu Z; Zhang H; Jiao J
BMC Cancer; 2021 Oct; 21(1):1085. PubMed ID: 34620126
[TBL] [Abstract][Full Text] [Related]
16. Circ_0003998 Regulates the Progression and Docetaxel Sensitivity of DTX-Resistant Non-Small Cell Lung Cancer Cells by the miR-136-5p/CORO1C Axis.
Zhang W; Song C; Ren X
Technol Cancer Res Treat; 2021; 20():1533033821990040. PubMed ID: 33511909
[TBL] [Abstract][Full Text] [Related]
17. Circ-POSTN promotes the progression and reduces radiosensitivity in esophageal cancer by regulating the miR-876-5p/FYN axis.
Chu A; Sun C; Liu Z; Liu S; Li M; Song R; Gan L; Wang Y; Fan R
Thorac Cancer; 2024 May; 15(13):1082-1094. PubMed ID: 38553795
[TBL] [Abstract][Full Text] [Related]
18. Circ-PVT1/miR-106a-5p/HK2 axis regulates cell growth, metastasis and glycolytic metabolism of oral squamous cell carcinoma.
Zhu X; Du J; Gu Z
Mol Cell Biochem; 2020 Nov; 474(1-2):147-158. PubMed ID: 32737775
[TBL] [Abstract][Full Text] [Related]
19. Circular RNA circ_0007142 regulates cell proliferation, apoptosis, migration and invasion via miR-455-5p/SGK1 axis in colorectal cancer.
Wen T; Wu H; Zhang L; Li K; Xiao X; Zhang L; Zhang Y
Anticancer Drugs; 2021 Jan; 32(1):22-33. PubMed ID: 32889894
[TBL] [Abstract][Full Text] [Related]
20. Circular RNA circ_0008450 regulates the proliferation, migration, invasion, apoptosis and chemosensitivity of CDDP-resistant nasopharyngeal carcinoma cells by the miR-338-3p/SMAD5 axis.
Liu L; Lu B; Li Y
Anticancer Drugs; 2022 Jan; 33(1):e260-e272. PubMed ID: 34387609
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
